C Luke
Overview
Explore the profile of C Luke including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
58
Citations
438
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Luke C, Nolan R, Duffy O, Hayes N
Ir Med J
. 2024 May;
117(5):961.
PMID: 38801133
No abstract available.
2.
Vaksmaa A, Luke C, van Alen T, Vale G, Lupotto E, Jetten M, et al.
FEMS Microbiol Ecol
. 2016 Aug;
92(12).
PMID: 27562776
In order to mitigate methane emissions from paddy fields, it is important to understand the sources and sinks. Most paddy fields are heavily fertilized with nitrite and nitrate, which can...
3.
Oostra C, Henke P, Luke C, Acino R, Lurie F, Comerota A
J Vasc Surg Venous Lymphat Disord
. 2016 Mar;
2(1):110.
PMID: 26992999
No abstract available.
4.
Bhat J, Rao V, Yadav R, Muniyandi M, Sharma R, Karfarma C, et al.
Indian J Med Res
. 2015 Jul;
141(5):636-9.
PMID: 26139782
Background & Objectives: The information on multidrug resistant tuberculosis (MDR-TB) situation amongst Saharia, one of the Particularly Vulnerable Tribal Groups (PVTGs) in Madhya Pradesh, India, is not available. Hence, this...
5.
Gulson B, Pisaniello D, McMichael A, Mizon K, Korsch M, Luke C, et al.
Environ Geochem Health
. 2013 Nov;
18(4):147-63.
PMID: 24194410
High-precision lead isotope ratios and lead concentrations have been compared statistically and graphically in women of child-bearing age (n = 77) from two smelter communities and one general urban community...
6.
Susskind M, Thurmann P, Luke C, Jeschke E, Tabali M, Matthes H, et al.
Evid Based Complement Alternat Med
. 2012 Feb;
2012:320760.
PMID: 22315630
Background. Anthroposophic medicine is one of the widely used approaches of complementary and alternative medicine. However, few prospective studies have generated safety data on its use. Objectives. We aimed to...
7.
Kristiansen G, Rose M, Geisler C, Fritzsche F, Gerhardt J, Luke C, et al.
Br J Cancer
. 2010 Jun;
102(12):1736-45.
PMID: 20531416
Background: We aimed to clarify the incidence and the clinicopathological value of non-muscle myoglobin (Mb) in a large cohort of non-invasive and invasive breast cancer cases. Methods: Matched pairs of...
8.
Luke M, Januschowski K, Luke J, Peters S, Wirtz N, Yoruk E, et al.
Br J Ophthalmol
. 2009 Jul;
93(10):1396-400.
PMID: 19628500
Background: Intraocular ranibizumab (Lucentis, Novartis, Basel Switzerland) is the primary choice in the treatment of neovascular age-related macular degeneration (AMD). Vascular endothelial growth factor (VEGF) is known to be a...
9.
Luke C, Tracey E, Stapleton A, Roder D
Intern Med J
. 2009 May;
40(5):357-62.
PMID: 19460053
Aim: To investigate trends in bladder cancer incidence, mortality and survival, and cancer-control implications. Methods: South Australian Registry data were used to calculate age-standardized incidence and mortality rates from 1980...
10.
Price T, Pittman K, Patterson W, Colbeck M, Rieger N, Hewett P, et al.
Clin Oncol (R Coll Radiol)
. 2008 Jun;
20(8):626-30.
PMID: 18524553
Aims: Significant improvements in the outcome for patients with advanced colorectal cancer (CRC) have been achieved. The median survival for advanced CRC reported in clinical trials now approaches 2 years,...